Prostatic Hyperplasia
Information
- Disease name
- Prostatic Hyperplasia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04760483 | Active, not recruiting | Phase 1 | Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA | November 20, 2020 | March 20, 2026 |
| NCT03228485 | Active, not recruiting | Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study | April 4, 2019 | September 30, 2024 | |
| NCT00062790 | Completed | Phase 4 | Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels | October 2003 | July 2005 |
| NCT00090103 | Completed | Phase 3 | Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment | November 2003 | April 2009 |
| NCT06319469 | Completed | Phase 2 | The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention | February 1, 2023 | January 30, 2024 |
| NCT00169585 | Completed | Phase 3 | Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) | March 2005 | April 2007 |
| NCT00280605 | Completed | Phase 4 | ALF-ONE : ALFuzosin ONcE Daily | August 2005 | February 2006 |
| NCT00290030 | Completed | Phase 3 | ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH | May 2001 | October 2004 |
| NCT00316732 | Completed | Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS | October 25, 2004 | December 19, 2006 | |
| NCT00368979 | Completed | Phase 3 | Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects | February 17, 2006 | December 6, 2007 |
| NCT00399464 | Completed | Phase 3 | Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia | November 2006 | October 2007 |
| NCT00401661 | Completed | Phase 4 | Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin | June 2006 | |
| NCT00408954 | Completed | Phase 2 | Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms | March 2007 | June 2008 |
| NCT00427882 | Completed | Phase 4 | Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study | September 2006 | May 2007 |
| NCT06257654 | Completed | One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia. | January 1, 2021 | December 31, 2023 | |
| NCT00457457 | Completed | Phase 2 | Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. | May 2007 | April 2008 |
| NCT00486785 | Completed | Phase 4 | SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin | April 2006 | March 2008 |
| NCT00510406 | Completed | Phase 2 | A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH | January 2007 | September 2007 |
| NCT00517179 | Completed | N/A | Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS | April 2006 | May 2007 |
| NCT00527605 | Completed | Phase 3 | Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) | October 2007 | March 2009 |
| NCT00537654 | Completed | Phase 1 | A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State | October 18, 2007 | February 22, 2008 |
| NCT00547625 | Completed | Phase 2 | Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems | October 2004 | July 2005 |
| NCT06148259 | Completed | N/A | SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes | March 12, 2021 | September 13, 2022 |
| NCT06116370 | Completed | N/A | The Clinical Efficacy of Rezūm Therapy Versus Bipolar Trans-urethral Resection of the Prostate for Treatment Benign Prostatic Hyperplasia | June 1, 2021 | September 1, 2023 |
| NCT00596011 | Completed | Phase 2 | Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia | November 14, 2007 | July 27, 2018 |
| NCT00609596 | Completed | Phase 1 | A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. | February 26, 2008 | April 23, 2008 |
| NCT00793819 | Completed | Phase 2 | A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia | January 2009 | October 2009 |
| NCT00814736 | Completed | Phase 1 | A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 | August 2008 | September 2008 |
| NCT00822952 | Completed | Prostate Mechanical Imager (PMI) Clinical Bridging Study | October 2008 | September 2009 | |
| NCT00885027 | Completed | MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment | March 2009 | ||
| NCT00969072 | Completed | Phase 2 | Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia | August 2003 | February 2005 |
| NCT01003886 | Completed | A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH) | May 2009 | January 2011 | |
| NCT01050465 | Completed | N/A | MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use | May 2009 | December 2010 |
| NCT01108367 | Completed | Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) | November 2009 | ||
| NCT01254071 | Completed | Phase 1 | A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. | September 10, 2010 | December 21, 2010 |
| NCT01262989 | Completed | Phase 1 | SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin | January 4, 2010 | January 26, 2010 |
| NCT01275521 | Completed | Phase 3 | A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy | January 10, 2011 | April 28, 2015 |
| NCT01294592 | Completed | Phase 4 | Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement | December 22, 2010 | October 17, 2013 |
| NCT01299571 | Completed | AVODART(Dutasteride) Post-marketing Surveillance(PMS) | December 2004 | July 2010 | |
| NCT01323998 | Completed | Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan | April 2010 | June 2010 | |
| NCT01330303 | Completed | Phase 1 | SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin | December 8, 2009 | December 22, 2009 |
| NCT01332435 | Completed | Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use | November 2009 | January 2010 | |
| NCT01332487 | Completed | Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia | August 2010 | August 2010 | |
| NCT01334723 | Completed | Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia | April 2010 | June 2010 | |
| NCT01376258 | Completed | Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database | October 2010 | December 2010 | |
| NCT01376284 | Completed | Drug Use Investigation for AVOLVE(BPH) | December 2010 | June 2014 | |
| NCT01381510 | Completed | Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database | June 2010 | August 2010 | |
| NCT01386983 | Completed | Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment | March 2009 | June 2010 | |
| NCT01390870 | Completed | Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence | May 2009 | September 2010 | |
| NCT01471678 | Completed | Phase 1 | Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. | June 30, 2011 | September 7, 2011 |
| NCT01482676 | Completed | The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction | October 2010 | December 2012 | |
| NCT01495026 | Completed | Phase 1 | A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia | November 6, 2011 | April 3, 2012 |
| NCT01577693 | Completed | Phase 1 | Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects | May 12, 2011 | August 31, 2011 |
| NCT01657851 | Completed | Phase 1 | Bioequivalence - Duodart Against Avodart & Omnic | August 23, 2012 | December 5, 2012 |
| NCT02846467 | Completed | N/A | Information Improvement for Surgical Patients Through Portable Video Media | December 2013 | April 2016 |
| NCT00029822 | Completed | Phase 3 | Clinical Trial in Males With BPH (Enlarged Prostate) | May 2001 | March 2005 |
| NCT02715401 | Completed | Phase 1 | PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers | October 2015 | November 2015 |
| NCT02737241 | Completed | N/A | HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH | June 1, 2015 | February 2018 |
| NCT02757963 | Completed | Phase 4 | Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years | May 12, 2016 | February 27, 2017 |
| NCT01767363 | Completed | WEUSKOP5723: Prostate Cancer Study | November 2012 | March 2016 | |
| NCT01777269 | Completed | Phase 4 | Prospective Sexual Function Study for BPH Subjects | February 18, 2013 | April 5, 2016 |
| NCT01957189 | Completed | Phase 1 | This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples | October 25, 2013 | January 22, 2014 |
| NCT05506735 | Completed | The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History | May 1, 2022 | August 17, 2022 | |
| NCT02058368 | Completed | Phase 3 | Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia | February 10, 2014 | March 3, 2017 |
| NCT00021814 | Completed | Phase 3 | Medical Therapy of Prostatic Symptoms | December 1995 | November 30, 2001 |
| NCT02184585 | Completed | Phase 1 | Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States | July 10, 2014 | February 23, 2015 |
| NCT04561505 | Completed | N/A | HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia | February 1, 2018 | February 29, 2020 |
| NCT04331301 | Completed | N/A | Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH | January 10, 2017 | March 10, 2022 |
| NCT03936244 | Completed | N/A | Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms | December 5, 2014 | December 12, 2019 |
| NCT02244229 | Completed | Phase 4 | Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients | April 1998 | |
| NCT02244242 | Completed | Phase 4 | Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia | July 1998 | |
| NCT02244255 | Completed | Phase 4 | FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia | August 1998 | |
| NCT02244268 | Completed | Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia | October 2000 | ||
| NCT02244307 | Completed | Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade | January 2000 | ||
| NCT02244320 | Completed | Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) | September 2002 | ||
| NCT02244333 | Completed | Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) | February 2004 | ||
| NCT02244346 | Completed | Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) | May 2004 | ||
| NCT02245490 | Completed | Phase 4 | Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms | January 2003 | |
| NCT02245503 | Completed | Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) | May 2003 | ||
| NCT02245529 | Completed | Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia | March 2005 | ||
| NCT02245542 | Completed | The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) | April 2005 | ||
| NCT02245555 | Completed | Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia | April 2006 | ||
| NCT02248467 | Completed | Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients | May 2013 | June 2018 | |
| NCT02252367 | Completed | Phase 4 | Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms | December 2015 | June 2020 |
| NCT03385161 | Completed | N/A | Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia | December 2013 | June 2017 |
| NCT02347436 | Completed | Does Benign Prostatic Obstruction Cause Hypertension? | February 2015 | October 31, 2019 | |
| NCT02366975 | Completed | Phase 4 | TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST | November 2012 | February 2017 |
| NCT02417831 | Completed | Phase 1 | Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. | April 30, 2015 | May 31, 2015 |
| NCT02417844 | Completed | Phase 1 | Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. | April 2015 | May 2015 |
| NCT02947958 | Completed | N/A | Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia | September 2014 | November 2016 |
| NCT02509104 | Completed | Phase 1 | Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects | July 30, 2015 | October 10, 2015 |
| NCT02578953 | Completed | Phase 1 | Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects | September 9, 2015 | December 15, 2015 |
| NCT02943070 | Completed | N/A | Rezum I Pilot Study for Benign Prostatic Hyperplasia | March 2012 | December 2018 |
| NCT02712411 | Completed | Phase 1 | Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers | July 2015 | September 2015 |
| NCT06209307 | Enrolling by invitation | N/A | Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate | February 8, 2024 | December 2024 |
| NCT05851521 | Not yet recruiting | N/A | To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES) | June 2023 | June 2025 |
| NCT06452927 | Not yet recruiting | N/A | EEP in Patients With Urodynamically Proven DU/DA | September 2024 | September 2028 |
| NCT04590534 | Recruiting | Phase 2 | Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH | August 1, 2020 | March 12, 2023 |
| NCT03354416 | Recruiting | Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer | February 26, 2018 | December 31, 2033 | |
| NCT05686525 | Recruiting | N/A | Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men With BPH | October 27, 2022 | December 2030 |
| NCT06001619 | Recruiting | Phase 4 | Prostate Medication, Metabolism and Gut Microbiota | December 1, 2022 | December 31, 2026 |
| NCT06091618 | Recruiting | N/A | Laser Vaporization of the Prostate: Comparing Between Ejaculatory Preserving and Non-ejaculatory Preserving Technique | August 1, 2022 | April 27, 2024 |
| NCT06161506 | Recruiting | Phase 2 | Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer | February 15, 2024 | March 1, 2025 |
| NCT06242119 | Recruiting | Clinical Application of the J-PET Scanner Prototype | March 7, 2024 | October 14, 2024 | |
| NCT06294366 | Recruiting | N/A | Bipolar Transurethral Enucleation Versus Resection in the Treatment of Benign Prostatic Hyperplasia: a Comparative Study | June 12, 2022 | June 12, 2024 |
| NCT00563654 | Terminated | N/A | Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up | October 2005 | November 2006 |
| NCT00563485 | Terminated | N/A | Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up | October 2005 | November 2006 |
| NCT04398966 | Terminated | N/A | Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia | September 23, 2020 | May 8, 2023 |
| NCT02396420 | Terminated | Phase 2 | Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams | September 24, 2015 | November 17, 2016 |
| NCT01673490 | Terminated | Phase 4 | Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia | June 29, 2012 | March 20, 2015 |
| NCT00116571 | Terminated | Phase 2 | Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) | May 2005 | December 2006 |
| NCT00454402 | Terminated | Phase 3 | ALF-STONE: Alfuzosin in Uretheric Stones | August 2006 | July 2007 |
| NCT02243085 | Unknown status | Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the Prostate | August 2014 | ||
| NCT02241902 | Unknown status | Impact of Postoperative Pyuria on Treatment Outcomes After PVP | August 2014 | ||
| NCT04588857 | Unknown status | Phase 4 | Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia | March 1, 2021 | June 1, 2023 |
| NCT02073799 | Unknown status | Storage Symptom After Laser Prostatectomy | February 2014 | ||
| NCT02033798 | Unknown status | N/A | The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia | February 2014 | June 2016 |
| NCT00044226 | Unknown status | Phase 2 | A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). | April 2002 | October 2002 |
| NCT02033785 | Unknown status | Functional Changes of Urogenital System After Holmium Laser Prostatectomy | February 2014 | March 2016 | |
| NCT00497939 | Unknown status | N/A | The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients | January 2006 | March 2008 |
| NCT02749604 | Unknown status | Phase 4 | Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate | March 2016 | March 2018 |
| NCT02592473 | Unknown status | N/A | Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia | November 2015 | November 2021 |
| NCT02496442 | Unknown status | N/A | Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan | July 2015 | December 2015 |
| NCT03064282 | Unknown status | Early Phase 1 | Prostatic Hyperplasia Treatment and Cancer Prevention | June 30, 2021 | December 1, 2021 |
| NCT03098147 | Unknown status | The Influence of Benign Prostatic Hyperplasia on Bladder Function | March 1, 2017 | April 2020 | |
| NCT05023824 | Unknown status | Phase 3 | Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH | December 8, 2020 | December 7, 2023 |
| NCT02278679 | Unknown status | Digital Rectal Exam Proficiency Tool | October 2014 | June 2018 | |
| NCT03554070 | Unknown status | N/A | Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety | March 1, 2018 | September 1, 2021 |
| NCT03589196 | Unknown status | N/A | Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT | March 10, 2018 | December 1, 2019 |
| NCT02243540 | Unknown status | Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy | April 2014 | ||
| NCT03955484 | Unknown status | Benign Prostatic Hyperplasia and Glycosaminoglycan | April 1, 2019 | November 1, 2019 | |
| NCT04108871 | Unknown status | N/A | Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men | October 3, 2018 | September 1, 2021 |
| NCT03179228 | Withdrawn | N/A | Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia | October 14, 2017 | June 1, 2028 |
| NCT03474419 | Withdrawn | Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Ambulatory Surgery | November 24, 2017 | December 31, 2018 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011470